PCG
EW icon

Prosperity Consulting Group’s Edwards Lifesciences EW Stock Holding History

Prosperity Consulting Group’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$306K Buy
3,824
+87
+2% +$7.17K 0.01% 418
2025
Q4 		$319K Buy
3,737
+96
+3% +$7.88K 0.01% 419
2025
Q3 		$283K Sell
3,641
-663
-15% -$51.8K 0.01% 425
2025
Q2 		$337K Buy
4,304
+132
+3% +$9.85K 0.02% 358
2025
Q1 		$302K Buy
4,172
+266
+7% +$19K 0.02% 367
2024
Q4 		$289K Buy
3,906
+134
+4% +$9.38K 0.02% 387
2024
Q3 		$249K Buy
+3,772
New +$274K 0.02% 406

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Prosperity Consulting Group's EW Position: Q1 2026 in Review

Prosperity Consulting Group increased its Edwards Lifesciences (EW) stake by 2.3% in Q1 2026, buying an estimated $7.17K and bringing the position to 3,824 shares worth $306K. The position accounts for 0.01% of the portfolio, ranked #418.

Prosperity Consulting Group first reported a position in EW in Q3 2024 and has held it in 7 quarters since. The position peaked at $337K in Q2 2025. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Prosperity Consulting Group held 3,824 shares of Edwards Lifesciences worth $306K as of Q1 2026.
  • Prosperity Consulting Group bought 87 Edwards Lifesciences shares in Q1 2026, an estimated $7.17K.
  • Edwards Lifesciences made up 0.01% of Prosperity Consulting Group's portfolio in Q1 2026, its #418 holding.
  • Prosperity Consulting Group first reported a position in Edwards Lifesciences in Q3 2024 and has held it in 7 quarters since.
  • Prosperity Consulting Group's Edwards Lifesciences position peaked at $337K in Q2 2025.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Prosperity Consulting Group's 13F filing for Q1 2026, filed 5 May 2026.